Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James B. Tananbaum currently holds 2,614,215 shares of Aimmune Therapeutics, Inc. (AIMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James B. Tananbaum has been a net buyer of AIMT stock. They have purchased $89.6M and sold $6.8M worth of shares.
James B. Tananbaum's most recent insider trade was on Nov 21, 2025, when they purchased 72,212 shares at $7.38 per share.
James B. Tananbaum serves as Executive at Aimmune Therapeutics, Inc. (AIMT). They have executed 79 insider transactions totaling $96.4M over their tenure at the company.
James B. Tananbaum holds the position of Executive at Aimmune Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
James B. Tananbaum has shown a buying trading pattern, with $89.6M in total purchases and $6.8M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James B. Tananbaum was on Jul 1, 2024, when they purchased $35.0M worth of ALMS shares. This transaction involved 2,187,500 shares at $16.00 per share.
James B. Tananbaum currently owns 2,614,215 shares of Aimmune Therapeutics, Inc. (AIMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James B. Tananbaum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James B. Tananbaum has 79 Form 4 filings on record as an insider at Aimmune Therapeutics, Inc..
Set alerts for James B. Tananbaum and 40,000+ other insiders.